ScienceDaily (Apr. 6, 2010) For patients with juvenile idiopathic arthritis in remission, withdrawal of treatment with the drug methotrexate over 12 months vs. 6 months did not reduce the rate of relapse, according to a study in the April 7 issue of JAMA.
See Also:Health & MedicineArthritisWounds and HealingJoint PainToday’s HealthcareMultiple Sclerosis ResearchDiseases and ConditionsReferenceInflammation of the kidneyCOX-2 inhibitorClinical trialRheumatoid arthritis
New therapies have improved the remission rate in chronic inflammatory disorders such as juvenile idiopathic arthritis (JIA; persistent or recurring inflammation of the joints similar to rheumatoid arthritis but beginning at or before age 16). "… physicians have to balance the risk of doing too little (e.g., withdrawing medication and provoking flares
View the Original article
